Presented by: Lindsey Maccoux, PhD, Global Product Manager, Protein Quantitation, Bio-Rad Laboratories, Inc.

Available on demand


High-quality scientific data relies on accurate and secure data handling procedures. However, knowing how to implement a regulation-compliant process in your western blot or gel electrophoresis imaging protocols isn’t always simple.

Join our upcoming webinar with Product Manager Lindsey Maccoux to discover how Bio-Rad’s Image Lab Software, Security Edition, can enhance data integrity in western blot and gel electrophoresis protocols by strengthening security measures while improving workflow efficiency in your research and support for regulatory requirements too.

During this live event, Maccoux will demonstrate how Bio-Rad’s imaging system family integrates features that support the enablement of regulatory compliance such as U.S. FDA 21 CFR Part 11 to facilitate the management of electronic records, signatures, and data integrity. Attendees will discover how to quickly establish and customize access permissions for both administrators and users within the Image Lab Touch modules. 

Join us to learn about:  

  • Regulatory compliance requirements and their relevance in western blot or gel electrophoresis imaging 
  • Bio-Rad’s imaging systems family and the integration of enhanced features for regulated environments 
  • How to master Image Lab Touch Software to set access permissions and adhere to regulatory compliance 
  • How to navigate the Image Lab Touch admin modules to activate additional features that support audit trail generation and increased compliance 
  • How to develop secure protocols for western blotting or gel electrophoresis imaging within regulatory compliance guidelines, enhancing data integrity and workflow efficiency 

Don’t miss this chance to learn from Product Manager Lindsey Maccoux.

Watch Webinar
Previous post

Introducing the ChemiDoc Go Imaging System: Modern Gel and Western Blot Imaging

Next post

Developing Efficient Downstream Purification Processes for Bispecific Antibodies